Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- GH
- Price
- 43.71
- Stock movement up
- +2.57 (6.25%)
- Company name
- Guardant Health Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 5.40B
- Ent value
- 6.31B
- Price/Sales
- 7.80
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -7.72%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 8.88%
- 1 year return
- 128.73%
- 3 year return
- -15.37%
- 5 year return
- -7.34%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
GH does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.80 |
| Price to Book | - |
| EV to Sales | 9.12 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 123.56M |
| EPS (TTM) | -4.16 |
| FCF per share (TTM) | -2.23 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 692.26M |
| Gross profit (TTM) | 561.18M |
| Operating income (TTM) | -515.14M |
| Net income (TTM) | -512.41M |
| EPS (TTM) | -4.16 |
| EPS (1y forward) | -2.08 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 81.07% |
| Operating margin (TTM) | -74.41% |
| Profit margin (TTM) | -74.02% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 688.37M |
| Net receivables | 88.47M |
| Total current assets | 1.23B |
| Goodwill | 3.29M |
| Intangible assets | 7.25M |
| Property, plant and equipment | 427.05M |
| Total assets | 1.54B |
| Accounts payable | 15.47M |
| Short/Current long term debt | 1.34B |
| Total current liabilities | 197.34M |
| Total liabilities | 1.60B |
| Shareholder's equity | -60.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -254.07M |
| Capital expenditures (TTM) | 20.29M |
| Free cash flow (TTM) | -274.36M |
| Dividends paid (TTM) | 21.19M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -33.30% |
| Return on Invested Capital | -46.20% |
| Cash Return on Invested Capital | -24.74% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 41.34 |
| Daily high | 43.94 |
| Daily low | 40.77 |
| Daily Volume | 2.17M |
| All-time high | 179.10 |
| 1y analyst estimate | 43.00 |
| Beta | 1.11 |
| EPS (TTM) | -4.16 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 Jun 2025 |
Downside potential
Loading...
Downside potential data
| GH | S&P500 | |
| Current price drop from All-time high | -75.59% | -12.89% |
| Highest price drop | -91.03% | -56.47% |
| Date of highest drop | 19 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -50.74% | -11.07% |
| Avg time to new high | 36 days | 12 days |
| Max time to new high | 1046 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
5.40B
Marketcap category
Mid-cap
Description
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Employees
1768
Website
Investor relations
SEC filings
CEO
Helmy Eltoukhy
Country
USA
City
Redwood City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page